approval
saveHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
community read0 votes
Sponsor: SANDOZ INC. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalOct 16, 2025 · 351d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalMay 20, 2025 · 500d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalJun 12, 2024 · 842d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalApr 5, 2024 · 910d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalSep 8, 2023 · 1120d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalApr 14, 2023 · 1267d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalMar 20, 2023 · 1292d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalJul 18, 2022 · 1537d ago
same company · ±60 days · 6
- approvalMEDROL: METHYLPREDNISOLONE — FDA approvalAug 1, 2025
- approvalMEDROL: METHYLPREDNISOLONE — FDA approvalAug 1, 2025
- approvalMEDROL: METHYLPREDNISOLONE — FDA approvalAug 1, 2025
- approvalsuccharated ferric oxide: IRON SUCROSE — FDA approvalAug 8, 2025
- approvalDIFLUPREDNATE: DUREZOL (DIFLUPREDNATE) — FDA approvalJul 15, 2025
- recallSandoz Inc recall (Cls I)Jul 9, 2025
comments(0)
5-min edit window · permanent after that